173 related articles for article (PubMed ID: 7755664)
1. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
4. [Rush immunotherapy of perennial allergic rhinitis].
Ito K
Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
[TBL] [Abstract][Full Text] [Related]
5. Topical nasal immunotherapy. Immunologic response of IgE in nasal secretion after immunotherapy with Dermatophagoides pteronyssinus.
Martín Mateos MA; Monferrer R; Muñoz López F
Allergol Immunopathol (Madr); 1990; 18(4):223-8. PubMed ID: 2264553
[TBL] [Abstract][Full Text] [Related]
6. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
7. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
9. Analysis of house dust mite-specific IgE, IgG4, and IgG antibodies during immunotherapy in asthmatic children.
Lin KL; Wang SY; Hsieh KH
Ann Allergy; 1991 Jul; 67(1):63-9. PubMed ID: 1859043
[TBL] [Abstract][Full Text] [Related]
10. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
11. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
Mungan D; Misirligil Z; Gürbüz L
Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
15. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
16. [The results of specific immunotherapy for house dust mites in patients with allergic rhinitis].
Sahin E; Taş E; Dağtekin Ergür EN; Cuhali BD; Gürsel AO
Kulak Burun Bogaz Ihtis Derg; 2008; 18(2):79-84. PubMed ID: 18628641
[TBL] [Abstract][Full Text] [Related]
17. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides.
Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E
Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284
[TBL] [Abstract][Full Text] [Related]
18. The value of total IgE determination in mite allergy.
de la Cuesta CG; García BE; Sanz ML; Feliu X; Oehling A
Allergol Immunopathol (Madr); 1989; 17(5):233-5. PubMed ID: 2610185
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
[TBL] [Abstract][Full Text] [Related]
20. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
Guez S; Vatrinet C; Fadel R; André C
Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
